Product Information
UCERIS 9 MG ER TABLET is a brand product labeled by Santarus Inc., priced at $57.1680 per EA under NDC 68012030930. Its NADAC has been published 524 times since Jul 23, 2014.
FDA first approved this application on Jan 14, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the budesonide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
9 mg/1
Manufacturer
Santarus Inc.NDC
68012030930
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
BUDESONIDEApproval Type
New Drug (NDA)
FDA Application
NDA203634FDA Approved
1/14/2013
TE Code
AB
On Market Since
1/14/2013
Pharmacological Classes
Price Statistics
The NADAC for UCERIS 9 MG ER TABLET has been published 524 times since Jul 23, 2014, and over the history we have for it it has risen 33.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $57.1680 per EA |
|---|---|
| All-time high | $57.5303 (Apr 15, 2020) |
| All-time low | $42.7462 (Aug 20, 2014) |
| 52-week high | $57.1680 |
| 52-week low | $57.1512 |
| Median price | $57.1028 |
| Average price | $54.4812 |
| Largest weekly change | +10.0% (Mar 25, 2015) |
| Weeks tracked | 524 |
| Tracking since | Jul 23, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+0.0%
3Y
+0.0%
5Y
+0.1%
All
+33.3%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of UCERIS 9 MG ER TABLET?
The current National Average Drug Acquisition Cost (NADAC) for UCERIS 9 MG ER TABLET, manufactured by Santarus Inc., is $57.1680 per EA (NDC 68012030930), effective Oct 1, 2025.
How has the price of UCERIS 9 MG ER TABLET changed over time?
Over the history we have for it, the NADAC for UCERIS 9 MG ER TABLET has risen 33.3%. It has been tracked across 524 weekly CMS publications since Jul 23, 2014.
What are the highest and lowest recorded NADAC prices for UCERIS 9 MG ER TABLET?
Since Jul 23, 2014, the NADAC for UCERIS 9 MG ER TABLET has ranged from a low of $42.7462 (Aug 20, 2014) to a high of $57.5303 (Apr 15, 2020), with a median of $57.1028 per EA.
Are there cheaper alternatives to UCERIS 9 MG ER TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE ER 9 MG TABLET, is $13.6545 per EA — about 76% below UCERIS 9 MG ER TABLET.
Who manufactures UCERIS 9 MG ER TABLET?
UCERIS 9 MG ER TABLET (NDC 68012030930) is labeled by Santarus Inc., and CMS classifies it as a brand product.